A synthesis of preclinical and population-level evidence now indicates that these agents may influence the development and progression of several OACs, particularly hepatocellular carcinoma (HCC), pancreatic cancer, and colorectal cancer (CRC)
However, its crucial to understand that compounded medications are not FDA-approved, which means that their stability and potency can vary based on the compounding process and ingredients used
Foundayo: the brand name for orforglipron, an oral GLP-1 medication that can be taken without food or water restrictions
Zinellu A, Mangoni AA
Collectively, these findings highlight semaglutides multifaceted role in CV risk reduction, including improvements in hemodynamic parameters, metabolic profiles, inflammatory status, and heart failure outcomes - all of which are implicated as part of kidney health